Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Laboratory and Clinical Medicine|January 1, 1985
Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrodK S Kant, V E Pollak, A Dosekun, et al.
Clinical Nephrology|October 1, 1985
Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin)X H Du, P Glas-Greenwalt, K S Kant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1990
Anthropometric norms for the dialysis populationE E Nelson, C D Hong, A L Pesce, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1986
Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpuraP Glas-Greenwalt, J M Hall, T W Panke, et al.
Prostaglandins|August 1, 1986
Beneficial effects of polyunsaturated fatty acids in partially nephrectomized ratsU O Barcelli, J Miyata, Y Ito, et al.
The Quarterly Journal of Medicine|November 1, 1988
Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effectsS Kim, N K Wadhwa, K S Kant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1985
Results of treatment in patients with end-stage renal disease: a multivariate analysis of risk factors and survival in 341 successive patientsG Garcia-Garcia, J A Deddens, R D'Achiardi-Rey, et al.
American Journal of Nephrology|January 1, 1982
Wegener's granulomatosis: prolonged patient survival after pneumonectomy and renal transplantationP K Chandran, M R First, M A Weiss, et al.
Pageof 8